National stakeholder preferences for next-generation rotavirus vaccines: Results from a six-country study

BACKGROUND: Currently available live, oral rotavirus vaccines (LORVs) have significantly reduced severe rotavirus hospitalizations and deaths worldwide. However, LORVs are not as effective in low- and middle-income countries (LMIC) where rotavirus disease burden is highest. Next-generation rotavirus...

Descripción completa

Detalles Bibliográficos
Autores principales: Price, Jessica, Mooney, Jessica, Bain, Carolyn, Bawa, John Tanko, Gurley, Nikki, Kumar, Amresh, Liyanage, Guwani, Mkisi, Rouden Esau, Odero, Chris, Seck, Karim, Simpson, Evan, Hausdorff, William P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Science 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8767494/
https://www.ncbi.nlm.nih.gov/pubmed/34863614
http://dx.doi.org/10.1016/j.vaccine.2021.11.009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8767494/
https://www.ncbi.nlm.nih.gov/pubmed/34863614
http://dx.doi.org/10.1016/j.vaccine.2021.11.009

Ejemplares similares